Insulet Asset Turnover vs Non Current Liabilities Total Analysis
PODD Stock | USD 166.19 2.02 1.23% |
Insulet financial indicator trend analysis is infinitely more than just investigating Insulet recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Insulet is a good investment. Please check the relationship between Insulet Asset Turnover and its Non Current Liabilities Total accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
Asset Turnover vs Non Current Liabilities Total
Asset Turnover vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Insulet Asset Turnover account and Non Current Liabilities Total. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Insulet's Asset Turnover and Non Current Liabilities Total is -0.34. Overlapping area represents the amount of variation of Asset Turnover that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Insulet, assuming nothing else is changed. The correlation between historical values of Insulet's Asset Turnover and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Asset Turnover of Insulet are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Asset Turnover i.e., Insulet's Asset Turnover and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | -0.34 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Asset Turnover
The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.Non Current Liabilities Total
Most indicators from Insulet's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Insulet current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.At present, Insulet's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 76.04, whereas Discontinued Operations is forecasted to decline to (2 M).
2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 500K | 9.8M | 28.9M | 30.3M | Tax Provision | 3.7M | 5.2M | 9.1M | 9.6M |
Insulet fundamental ratios Correlations
Click cells to compare fundamentals
Insulet Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Insulet fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.1B | 1.9B | 2.0B | 2.3B | 2.6B | 2.7B | |
Total Stockholder Equity | 75.9M | 603.6M | 556.3M | 476.4M | 732.7M | 769.3M | |
Net Debt | 511.8M | 96.1M | 457.2M | 727.1M | 798.1M | 838.0M | |
Cash | 376.1M | 947.6M | 791.6M | 674.7M | 650.7M | 683.2M | |
Other Assets | 25M | 79M | 106.1M | 147.1M | 1.0 | 0.95 | |
Cash And Short Term Investments | 376.1M | 947.6M | 791.6M | 674.7M | 704.2M | 739.4M | |
Common Stock Shares Outstanding | 62.3M | 65.9M | 68.6M | 69.9M | 73.6M | 44.7M | |
Liabilities And Stockholders Equity | 1.1B | 1.9B | 2.0B | 2.3B | 2.6B | 2.7B | |
Other Stockholder Equity | 749M | 1.3B | 1.2B | 1.0B | 1.1B | 620.4M | |
Total Liab | 1.1B | 1.3B | 1.5B | 1.8B | 1.9B | 1.9B | |
Total Current Assets | 591M | 1.2B | 1.3B | 1.3B | 1.6B | 1.6B | |
Short Long Term Debt Total | 887.9M | 1.0B | 1.2B | 1.4B | 1.4B | 1.5B | |
Other Current Liab | 96.4M | 132.7M | 162.5M | 290.3M | 363.7M | 381.9M | |
Total Current Liabilities | 157.7M | 207.8M | 228.8M | 364.7M | 451.2M | 473.8M | |
Property Plant And Equipment Net | 399.4M | 478.7M | 536.5M | 599.9M | 692.8M | 727.4M | |
Current Deferred Revenue | 3.2M | 5.4M | 3.5M | 16.1M | 15.4M | 16.2M | |
Retained Earnings | (672M) | (666.3M) | (649.5M) | (584.3M) | (378M) | (396.9M) | |
Accounts Payable | 54.5M | 54.1M | 37.7M | 30.8M | 19.2M | 19.7M | |
Non Current Assets Total | 551.9M | 624.2M | 719M | 937.1M | 1.0B | 1.1B | |
Non Currrent Assets Other | 41.1M | 77M | 106.1M | 210M | 178.7M | 187.6M | |
Non Current Liabilities Total | 909.3M | 1.1B | 1.3B | 1.4B | 1.4B | 1.5B | |
Other Current Assets | 31.1M | 63M | 74M | 86.9M | 99.8M | 104.8M | |
Property Plant And Equipment Gross | 399.4M | 478.7M | 715.7M | 834.6M | 958.1M | 1.0B | |
Accumulated Other Comprehensive Income | (1.2M) | 5.5M | (2.2M) | 20M | 8M | 8.4M | |
Other Liab | 7M | 17.8M | 14.9M | 8.3M | 9.5M | 5.4M | |
Long Term Debt | 887.9M | 1.0B | 1.2B | 1.4B | 1.4B | 1.4B | |
Net Receivables | 82.8M | 83.8M | 161M | 205.6M | 359.7M | 377.7M | |
Short Term Investments | 175.0M | 162.4M | 40.4M | 50.8M | 53.5M | 63.8M | |
Inventory | 101M | 154.3M | 303.2M | 346.8M | 402.6M | 422.7M | |
Property Plant Equipment | 399.4M | 478.7M | 536.5M | 599.9M | 689.9M | 724.4M | |
Net Tangible Assets | 22.9M | 535.1M | 479.9M | 349.2M | 401.6M | 421.7M | |
Good Will | 39.8M | 39.6M | 39.8M | 51.7M | 59.5M | 44.1M | |
Retained Earnings Total Equity | (672M) | (666.3M) | (649.5M) | (584.3M) | (525.9M) | (552.2M) | |
Long Term Debt Total | 887.9M | 1.0B | 1.2B | 1.4B | 1.6B | 1.7B | |
Capital Surpluse | 749M | 1.3B | 1.2B | 1.0B | 1.2B | 899.1M | |
Deferred Long Term Liab | 19.9M | 21.9M | 26.1M | 31.3M | 36.0M | 37.8M | |
Non Current Liabilities Other | 21.4M | 17.8M | 14.9M | 35.7M | 37.9M | 39.8M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insulet using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.Note that the Insulet information on this page should be used as a complementary analysis to other Insulet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.043 | Earnings Share 2.94 | Revenue Per Share 24.331 | Quarterly Revenue Growth 0.379 | Return On Assets 0.0609 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.